Paediatric Oncology at the Crossroads: A Call for Change

Pharmaceut Med. 2020 Oct;34(5):297-300. doi: 10.1007/s40290-020-00352-x.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adolescent
  • Age of Onset
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Drug Approval / legislation & jurisprudence*
  • Humans
  • Infant
  • Infant, Newborn
  • Medical Oncology / legislation & jurisprudence*
  • Neoplasms / diagnosis
  • Neoplasms / drug therapy*
  • Neoplasms / epidemiology
  • Off-Label Use / legislation & jurisprudence*
  • Patient Safety
  • Pediatrics / legislation & jurisprudence*
  • Policy Making*
  • Risk Assessment
  • Young Adult

Substances

  • Antineoplastic Agents